Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc.SHPH · Entity 8505 | Director | August 08, 2025 | August 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Shuttle Pharmaceuticals Holdings, Inc.
Report date August 08, 2025 · Filed August 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 29,240 |
Reported balance
After 2025-08-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-08-08 · Grant · Acquired 29,240 · Balance 29,240 F1: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.
F2: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 08, 2025 Filed Aug 13, 2025 12:33 UTC | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | GrantRestricted Stock Unit · Derivative | 29,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023376 · ownership.xml · derivative · entry 1 Richards Steven M · CIK 0001945980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,240 Underlying: Common Stock · 29,240 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. Read SEC document |
| December 31, 2024 Filed Feb 3, 2025 19:30 UTC | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | GrantCommon Stock | 209,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-004732 · ownership.xml · nonDerivative · entry 1 Richards Steven M · CIK 0001945980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,004 F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting. Read SEC document |
| December 23, 2024 Filed Feb 6, 2025 19:33 UTC Amendment | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | GrantCommon Stock | 209,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-005265 · ownership.xml · nonDerivative · entry 1 Richards Steven M · CIK 0001945980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,004 F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting. Read SEC document |
| December 29, 2022 Filed Jan 9, 2023 16:10 UTC | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | SaleCOMMON STOCK | 995 | $1.61 | $1,596.98 |
DisclosureSEC source: 0001493152-23-000941 · ownership.xml · nonDerivative · entry 1 Richards Steven M · CIK 0001945980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,707 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 1,707 shares of SHPH common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.